Macfarlanes LLP remains highly active across both regulatory appeals and private litigation, including individual damages claims and collective proceedings. Recent regulatory highlights include acting in high-profile appeals before the CAT against CMA pricing decisions. The group is also advising on a wide range of private competition claims, including several of the few cartel damages actions progressing to trial. Practice head Cameron Firth is an experienced litigator who has played a leading role in appeals against CMA decisions and major disputes before the English and EU courts. Simon Day is a trusted adviser to clients involved in complex antitrust litigation and group actions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Macfarlanes competition team has a unique ability to combine its expertise with that of the firm's commercial litigators, to make one of the most formidable competition litigation teams in the city.’
‘Cameron Firth is a leading talent in the competition law world. He is known to everyone operating in the area and is involved in all the major cases.'
‘Led by the charismatic and immensely hardworking Cameron Firth, the team has hands-on experience from many of the leading competition law cases in recent years. ’
‘Cameron Firth remains involved in the legal issues and strategy of his cases on a day-to-day basis. Excellent at managing a large litigation team and giving clients top-flight personal attention.'
- 'Simon Day - erudite and creative lawyer, who goes the extra mile for his clients.'
‘I worked with Macfarlanes on two different projects. One team was led by Cameron Firth, and another by Simon Day. I think the people at Macfarlanes are very competent and pleasant to work with, and generally very responsive.'
Key clients
- Auden Mckenzie Pharmaceuticals
- ZF Friedrichshafen
- Prysmian Cavi e Sistemi Srl and Prysmian SpA
- Daimler Truck
- NatWest Markets
- Flynn Pharma
- PRS for Music
- Arrow Generics Limited
Work highlights
Advising Flynn Pharma on its successful overturning of the CMA’s remittal decision on unfair pricing.
Advising ZF in its defence of damages claims brought by Stellantis with the Tribunal dismissing Stellantis’ claims.
Advising PRS in its defence of proposed collective proceedings brought by David Rowntree in relation to alleged unfair practices in relation to the distribution of music royalties.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Cameron Firth
Other key lawyers
Emma Radcliffe; Malcolm Walton; Simon Day; Tom Usher; Caja Griesenbach; Alex Evans; Jenny Reeves